荷兰临床实践中常规诊断性腹腔镜指导晚期上皮性卵巢癌初始治疗的实施:支持度评估与预算影响分析
该研究评估2017—2019年荷兰晚期上皮性卵巢癌(EOC)治疗规划中常规诊断性腹腔镜(DLS)的临床应用,采用卫生技术评估结合半结构式调查与预算影响分析。DLS使用率从16%升至20%,多数中心不支持常规实施;作者建议仅在传统检查无法确定初次CRS能否成功时使用DLS。
要点
- DLS使用率从16%升至20%,多数中心因后勤障碍和侵袭性不支持常规实施。
- 初次CRS比例从44%降至36%, unsuccessful初次CRS率从15%降至9%。
核心结论
- 在荷兰,常规DLS指导晚期EOC治疗规划的实施支持有限;多年来总医疗费用下降;作者建议当传统检查无法确定初次CRS能否成功时,DLS有用。
研究设计与样本
- 2017—2019年期间实施的卫生技术评估,涵盖临床、组织与经济因素;通过半结构式调查识别实施障碍并评估DLS使用;使用荷兰妇科肿瘤审计数据确定CRS成功率;对DLS联合初次CRS进行预算影响分析(BIA)。
主要发现
- 指导治疗规划的DLS使用率从16%升至20%。
- 多数中心不支持常规DLS实施,主要因后勤障碍及其侵袭性。
- 所有CRS中初次CRS比例从44%降至36%,转向间隔CRS。
- unsuccessful初次CRS率从15%降至9%,需要第二次间隔CRS的患者减少。
关键数值与推荐
- DLS使用率从16%升至20%。
- 初次CRS比例从44%降至36%。
- unsuccessful初次CRS率从15%降至9%。
临床怎么用
- 作者建议:当基于传统检查不确定初次CRS能否成功时,DLS有用。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In patients with advanced-stage epithelial ovarian cancer (EOC), a diagnostic laparoscopy (DLS) to determine treatment regime prevents futile laparotomies and seems cost-neutral. The uptake of DLS in current practice is unknown. We evaluated the clinical application of routine DLS in treatment planning in patients with advanced-stage EOC in the Netherlands. METHODS: The implementation was evaluated over the period 2017-2019, using a health technology assessment including clinical, organizational, and economic factors. Barriers for implementation were identified and DLS use was assessed using semi-structured surveys with healthcare professionals. Data from the Dutch Gynecological Oncology Audit were used to determine (un)successful CRS rates. To assess the economic impact, we performed a budget impact analysis (BIA) of the combined interventions of DLS and primary CRS. RESULTS: The DLS use to guide treatment planning increased from 16% to 20%. The majority of the centers did not support routine DLS implementation, mainly because of logistic barriers and its invasive nature. The primary CRS rate of all CRS decreased from 44% to 36%, in favor of interval CRS. The unsuccessful primary CRS rate decreased from 15% to 9% resulting in fewer patients needed a second interval CRS. Consequently, total health care costs decreased from €4.457.496 to €4.274.751. CONCLUSIONS: The implementation of routine DLS for guiding treatment planning in patients with advanced-stage EOC has limited support in the Netherlands. Over the years, total health care costs decreased. For current practice, it is advised that a DLS is useful in case it is uncertain whether a successful primary CRS is feasible based on conventional work-up.
引用
- Lof P, Retèl VP, Algera MD, et al. Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis. Gynecol Oncol. 2022. PMID: 35414427. doi:10.1016/j.ygyno.2022.03.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。